Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)

NCT01421498 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

588

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca
Dry Eye Disease

Interventions

DRUG: Lifitegrast
DRUG: Placebo

Sponsor

Shire